Filgrastim biosimilar (Claris Lifesciences)

非格司亭生物类似药（Claris Lifesciences）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameFilgrastim biosimilar (Claris Lifesciences)

Drug Alias NameRecombinant human granulocyte macrophage colony stimulating factor (Claris Lifesciences)重组人粒细胞刺激因子（Claris Lifesciences）非格司亭生物仿制药（Claris Lifesciences）Recombinant G-CSF (Claris Lifesciences)rhG-CSF (Claris Lifesciences) +[6]

ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokinesBiologics > Biosimilar

Mechanisms of ActionColony stimulating factor 3 receptor agonists

TargetsColony stimulating factor 3 receptor

Therapy Area/IndicationsNeutropenia

Global Approved IndicationsNeutropenia

Approved Indications in ChinaN/A

Original Approved Country/TerritoryIndia

Original Approved Date2012/01/01

Country/TerritoryIndia

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesClaris Lifesciences Ltd

China Registration ClassN/A

Develop Information

Active CompaniesClaris Lifesciences Ltd

Inactive CompaniesN/A

Active IndicationsNeutropenia

Inactive IndicationsN/A

Other Information

ATC CodeL03AA02